Publications from OUS - Experimental Immunotherapy (Olweus)

79 publications found

Publications 2025

1. Champagne J, Nielsen MM, Feng X, Montenegro Navarro J, Pataskar A, Voogd R, Giebel L, Nagel R, Berenst N, Fumagalli A, Kochavi A, Lovecchio D, Valcanover L, Malka Y, Yang W, Laos M, Li Y, Proost N, van de Ven M, van Tellingen O, Bleijerveld OB, Haanen JBAG, Olweus J, Agami R (2025)
   Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
   Immunity, 58 (1), 247-262.e9
   DOI 10.1016/j.immuni.2024.12.004, PubMed 39755122
2. Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J (2025)
   TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
   Nat Immunol, 26 (10), 1726-1736
   DOI 10.1038/s41590-025-02252-1, PubMed 40866620
3. Foldvari Z, Brennan MS, Titov A, Jacobsen SEW, Olweus J (2025)
   Targeting the roots of myeloid malignancies with T cell receptors
   Nat Rev Cancer (in press)
   DOI 10.1038/s41568-025-00857-0, PubMed 40841587
4. Mamia K, Kolbeinsdottir S, Labun K, Li Z, Komisarczuk A, Keskitalo S, Reint G, Loe Haugen F, Olaug Lindestad B, Skundberg Jensen S, Gjerdingen TJ, Tuhkala A, Wieczorek Ervik C, Kopcil P, Fatkhutdinov N, Bronken Martinsen KH, Erichsen HC, Szymanska M, Tölö E, Glumoff V, Saarela J, Melbye Michelsen T, Schalin-Jäntti C, Olweus J, Leinonen E et al. (2025)
   Precision T cell correction platform for inborn errors of immunity
   Mol Ther (in press)
   DOI 10.1016/j.ymthe.2025.08.018, PubMed 40808259
5. Rosenberger L, Hansmann L, Anastasopoulou V, Wolf SP, Drousch K, Moewes C, Feng X, Cao G, Huang J, Yew PY, Strønen E, Kato T, Saligrama N, Olweus J, Nakamura Y, Willimsky G, Blankenstein T, Schreiber H, Leisegang M (2025)
   Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire
   J Immunother Cancer, 13 (5)
   DOI 10.1136/jitc-2024-011351, PubMed 40316304
6. Weller C, Bartok O, McGinnis CS, Palashati H, Chang TG, Malko D, Shmueli MD, Nagao A, Hayoun D, Murayama A, Sakaguchi Y, Poulis P, Khatib A, Erlanger Avigdor B, Gordon S, Cohen Shvefel S, Zemanek MJ, Nielsen MM, Boura-Halfon S, Sagie S, Gumpert N, Yang W, Alexeev D, Kyriakidou P, Yao W et al. (2025)
   Translation dysregulation in cancer as a source for targetable antigens
   Cancer Cell, 43 (5), 823-840.e18
   DOI 10.1016/j.ccell.2025.03.003, PubMed 40154482

Publications 2024

1. Chojnacka M, Diamond B, Ziccheddu B, Rustad E, Maclachlan K, Papadimitriou M, Boyle EM, Blaney P, Usmani S, Morgan G, Landgren O, Maura F (2024)
   Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma
   Clin Cancer Res, 30 (3), 575-585
   DOI 10.1158/1078-0432.CCR-23-1045, PubMed 37939148
2. Fageräng B, Cyranka L, Schjalm C, McAdam KE, Larsen CS, Heinzelbecker J, Gedde-Dahl T, Würzner R, Espevik T, Tjønnfjord GE, Garred P, Barratt-Due A, Tvedt THA, Mollnes TE (2024)
   The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation
   Front Immunol, 15, 1422370
   DOI 10.3389/fimmu.2024.1422370, PubMed 38938578
3. Imbery JF, Wiik C, Heinzelbecker J, Jebsen JK, Dobbing MK, Bottini N, Stanford SM, Munthe LA, Tjønnfjord GE, Tveita A, Szodoray P, Nakken B (2024)
   CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
   Mol Ther Oncol, 32 (3), 200841
   DOI 10.1016/j.omton.2024.200841, PubMed 39474602
4. Ma J, Meyer S, Olweus J, Jin C, Yu D (2024)
   An adjusted droplet digital PCR assay for quantification of vector copy number in CAR-T cell and TCR-T cell products
   Immunooncol Technol, 25, 101031
   DOI 10.1016/j.iotech.2024.101031, PubMed 40236328

Publications 2023

1. Boyle EM, Blaney P, Stoeckle JH, Wang Y, Ghamlouch H, Gagler D, Braunstein M, Williams L, Tenenbaum A, Siegel A, Chen X, Varma G, Avigan J, Li A, Jinsi M, Kaminetzsky D, Arbini A, Montes L, Corre J, Rustad EH, Landgren O, Maura F, Walker BA, Bauer M, Bruno B et al. (2023)
   Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
   Clin Cancer Res, 29 (19), 3901-3913
   DOI 10.1158/1078-0432.CCR-22-3209, PubMed 37449980
2. Foldvari Z, Knetter C, Yang W, Gjerdingen TJ, Bollineni RC, Tran TT, Lund-Johansen F, Kolstad A, Drousch K, Klopfleisch R, Leisegang M, Olweus J (2023)
   A systematic safety pipeline for selection of T-cell receptors to enter clinical use
   NPJ Vaccines, 8 (1), 126
   DOI 10.1038/s41541-023-00713-y, PubMed 37607971
3. Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl T et al. (2023)
   A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
   Nat Cancer, 4 (10), 1474-1490
   DOI 10.1038/s43018-023-00642-8, PubMed 37783807
4. Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, Yang W, Nissen-Meyer LSH, Douvlataniotis K, Laos M, Nielsen MM, Thiede B, Søraas A, Lund-Johansen F, Rustad EH, Olweus J (2023)
   Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
   Cell Rep, 42 (1), 111995
   DOI 10.1016/j.celrep.2023.111995, PubMed 36656713
5. Shah UA, Whiting K, Devlin S, Ershler R, Kanapuru B, Lee DJ, Tahri S, Gwise T, Rustad EH, Mailankody S, Lesokhin AM, Kazandjian D, Maura F, Auclair D, Birmann BM, Usmani SZ, Gormley N, Marinac CR, Landgren O (2023)
   Extreme body mass index and survival in newly diagnosed multiple myeloma patients
   Blood Cancer J, 13 (1), 13
   DOI 10.1038/s41408-022-00782-7, PubMed 36631444
6. Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K et al. (2023)
   Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
   Blood Adv, 7 (23), 7216-7230
   DOI 10.1182/bloodadvances.2023010158, PubMed 37695745

Publications 2022

1. Ali M, Fulci G, Grigalavicius M, Pulli B, Li A, Wojtkiewicz GR, Wang C, Hsieh KL, Linnoila JJ, Theodossiou TA, Chen JW (2022)
   Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy
   Neoplasia, 26, 100779
   DOI 10.1016/j.neo.2022.100779, PubMed 35247801
2. Bollineni RC, Tran TT, Lund-Johansen F, Olweus J (2022)
   Chasing neoantigens; invite naïve T cells to the party
   Curr Opin Immunol, 75, 102172
   DOI 10.1016/j.coi.2022.102172, PubMed 35279483
3. Hultcrantz M, Rustad EH, Yellapantula V, Jacob A, Akhlaghi T, Korde N, Mailankody S, Lesokhin AM, Hassoun H, Smith EL, Lahoud OB, Landau HJ, Shah GL, Scordo M, Chung DJ, Giralt S, Papaemmanuil E, Landgren O (2022)
   Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma
   Clin Cancer Res, 28 (10), 2160-2166
   DOI 10.1158/1078-0432.CCR-20-2995, PubMed 35553646
4. Imbery JF, Heinzelbecker J, Jebsen JK, McGowan M, Myklebust C, Bottini N, Stanford SM, Skånland SS, Tveita A, Tjønnfjord GE, Munthe LA, Szodoray P, Nakken B (2022)
   T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation
   Br J Haematol, 198 (3), 556-573
   DOI 10.1111/bjh.18285, PubMed 35655388
5. König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO (2022)
   Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
   JAMA Neurol, 79 (3), 307-309
   DOI 10.1001/jamaneurol.2021.5109, PubMed 35072702
6. Misund K, Hofste Op Bruinink D, Coward E, Hoogenboezem RM, Rustad EH, Sanders MA, Rye M, Sponaas AM, van der Holt B, Zweegman S, Hovig E, Meza-Zepeda LA, Sundan A, Myklebost O, Sonneveld P, Waage A (2022)
   Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
   Leukemia, 36 (7), 1887-1897
   DOI 10.1038/s41375-022-01597-y, PubMed 35643867
7. Pataskar A, Champagne J, Nagel R, Kenski J, Laos M, Michaux J, Pak HS, Bleijerveld OB, Mordente K, Navarro JM, Blommaert N, Nielsen MM, Lovecchio D, Stone E, Georgiou G, de Gooijer MC, van Tellingen O, Altelaar M, Joosten RP, Perrakis A, Olweus J, Bassani-Sternberg M, Peeper DS, Agami R (2022)
   Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
   Nature, 603 (7902), 721-727
   DOI 10.1038/s41586-022-04499-2, PubMed 35264796
8. Pataskar A, Champagne J, Nagel R, Kenski J, Laos M, Michaux J, Pak HS, Bleijerveld OB, Mordente K, Navarro JM, Blommaert N, Nielsen MM, Lovecchio D, Stone E, Georgiou G, de Gooijer MC, van Tellingen O, Altelaar M, Joosten RP, Perrakis A, Olweus J, Bassani-Sternberg M, Peeper DS, Agami R (2022)
   Author Correction: Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
   Nature, 608 (7922), E20
   DOI 10.1038/s41586-022-05097-y, PubMed 35840685
9. Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
   Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
   Br J Haematol, 197 (6), 697-708
   DOI 10.1111/bjh.18149, PubMed 35254660

Publications 2021

1. Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT et al. (2021)
   T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
   Nat Biotechnol, 40 (4), 488-498
   DOI 10.1038/s41587-021-01089-x, PubMed 34873326
2. König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
   Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
   J Neurol Neurosurg Psychiatry, 94 (1), 19-22
   DOI 10.1136/jnnp-2021-327612, PubMed 34670844
3. Maclachlan KH, Rustad EH, Derkach A, Zheng-Lin B, Yellapantula V, Diamond B, Hultcrantz M, Ziccheddu B, Boyle EM, Blaney P, Bolli N, Zhang Y, Dogan A, Lesokhin AM, Morgan GJ, Landgren O, Maura F (2021)
   Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
   Nat Commun, 12 (1), 5172
   DOI 10.1038/s41467-021-25469-8, PubMed 34453055
4. Maura F, Boyle EM, Rustad EH, Ashby C, Kaminetzky D, Bruno B, Braunstein M, Bauer M, Blaney P, Wang Y, Ghamlouch H, Williams L, Stoeckle J, Davies FE, Walker BA, Maclachlan K, Diamond B, Landgren O, Morgan GJ (2021)
   Chromothripsis as a pathogenic driver of multiple myeloma
   Semin Cell Dev Biol, 123, 115-123
   DOI 10.1016/j.semcdb.2021.04.014, PubMed 33958284
5. Mazzarella L, Enblad G, Olweus J, Malmberg KJ, Jerkeman M (2021)
   Advances in immune therapies in hematological malignancies
   J Intern Med, 292 (2), 205-220
   DOI 10.1111/joim.13395, PubMed 34624160
6. Mester S, Evers M, Meyer S, Nilsen J, Greiff V, Sandlie I, Leusen J, Andersen JT (2021)
   Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo
   MAbs, 13 (1), 1893888
   DOI 10.1080/19420862.2021.1893888, PubMed 33691596
7. Rustad EH, Nadeu F, Angelopoulos N, Ziccheddu B, Bolli N, Puente XS, Campo E, Landgren O, Maura F (2021)
   mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies
   Commun Biol, 4 (1), 424
   DOI 10.1038/s42003-021-01938-0, PubMed 33782531

Publications 2020

1. Ask EH, Tschan-Plessl A, Gjerdingen TJ, Sætersmoen ML, Hoel HJ, Wiiger MT, Olweus J, Wahlin BE, Lingjærde OC, Horowitz A, Cashen AF, Watkins M, Fehniger TA, Holte H, Kolstad A, Malmberg KJ (2020)
   A Systemic Protein Deviation Score Linked to PD-1⁺ CD8⁺ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma
   Med, 2 (2), 180-195.e5
   DOI 10.1016/j.medj.2020.10.006, PubMed 35590201
2. Bartok O, Pataskar A, Nagel R, Laos M, Goldfarb E, Hayoun D, Levy R, Körner PR, Kreuger IZM, Champagne J, Zaal EA, Bleijerveld OB, Huang X, Kenski J, Wargo J, Brandis A, Levin Y, Mizrahi O, Alon M, Lebon S, Yang W, Nielsen MM, Stern-Ginossar N, Altelaar M, Berkers CR et al. (2020)
   Anti-tumour immunity induces aberrant peptide presentation in melanoma
   Nature, 590 (7845), 332-337
   DOI 10.1038/s41586-020-03054-1, PubMed 33328638
3. Evers M, Ten Broeke T, Jansen JHM, Nederend M, Hamdan F, Reiding KR, Meyer S, Moerer P, Brinkman I, Rösner T, Lebbink RJ, Valerius T, Leusen JHW (2020)
   Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
   MAbs, 12 (1), 1795505
   DOI 10.1080/19420862.2020.1795505, PubMed 32744145

Publications 2019

1. Ali M, Foldvari Z, Giannakopoulou E, Böschen ML, Strønen E, Yang W, Toebes M, Schubert B, Kohlbacher O, Schumacher TN, Olweus J (2019)
   Induction of neoantigen-reactive T cells from healthy donors
   Nat Protoc, 14 (6), 1926-1943
   DOI 10.1038/s41596-019-0170-6, PubMed 31101906
2. Olweus J, Lund-Johansen F (2019)
   Finding Neo (antigens, that is)
   Blood, 134 (2), 108-109
   DOI 10.1182/blood.2019001334, PubMed 31296544
3. Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q, Berg K (2019)
   Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
   NPJ Breast Cancer, 5, 13
   DOI 10.1038/s41523-019-0108-8, PubMed 30993194

Publications 2018

1. Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ (2018)
   Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
   Cancer Immunol Res, 6 (4), 467-480
   DOI 10.1158/2326-6066.CIR-17-0207, PubMed 29459477

Publications 2017

1. Jha SK, Rauniyar K, Karpanen T, Leppänen VM, Brouillard P, Vikkula M, Alitalo K, Jeltsch M (2017)
   Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
   Sci Rep, 7 (1), 4916
   DOI 10.1038/s41598-017-04982-1, PubMed 28687807
2. Karpanen T, Olweus J (2017)
   The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
   Front Immunol, 8, 1718
   DOI 10.3389/fimmu.2017.01718, PubMed 29321773
3. Olweus J (2017)
   Manufacture of CAR-T cells in the body
   Nat Biotechnol, 35 (6), 520-521
   DOI 10.1038/nbt.3898, PubMed 28591119
4. Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund MB, Aaløkken TM, Taraldsrud E, Hetlevik SO, Molberg Ø (2017)
   Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
   Arthritis Res Ther, 19 (1), 284
   DOI 10.1186/s13075-017-1494-7, PubMed 29268795
5. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
   Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
   Sci Rep, 7, 39710
   DOI 10.1038/srep39710, PubMed 28054583
6. Taraldsrud E, Fevang B, Jørgensen SF, Moltu K, Hilden V, Taskén K, Aukrust P, Myklebust JH, Olweus J (2017)
   Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
   J Autoimmun, 81, 110-119
   DOI 10.1016/j.jaut.2017.04.004, PubMed 28476239

Publications 2016

1. Henriksen EK, Jørgensen KK, Kaveh F, Holm K, Hamm D, Olweus J, Melum E, Chung BK, Eide TJ, Lundin KE, Boberg KM, Karlsen TH, Hirschfield GM, Liaskou E (2016)
   Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
   J Hepatol, 66 (1), 116-122
   DOI 10.1016/j.jhep.2016.09.002, PubMed 27647428
2. Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J (2016)
   Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
   Oncoimmunology, 5 (5), e1138199
   DOI 10.1080/2162402X.2016.1138199, PubMed 27467957
3. Strønen E, Toebes M, Kelderman S, van Buuren MM, Yang W, van Rooij N, Donia M, Böschen ML, Lund-Johansen F, Olweus J, Schumacher TN (2016)
   Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
   Science, 352 (6291), 1337-41
   DOI 10.1126/science.aaf2288, PubMed 27198675
4. Taraldsrud E, Aukrust P, Jørgensen S, Lingjærde OC, Olweus J, Myklebust JH, Fevang B (2016)
   Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency
   Clin Immunol, 175, 69-74
   DOI 10.1016/j.clim.2016.11.014, PubMed 27919819

Publications 2015

1. Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA (2015)
   Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
   Gene Ther, 22 (5), 391-403
   DOI 10.1038/gt.2015.4, PubMed 25652098
2. Karpanen T, Olweus J (2015)
   T-cell receptor gene therapy--ready to go viral?
   Mol Oncol, 9 (10), 2019-42
   DOI 10.1016/j.molonc.2015.10.006, PubMed 26548533
3. Kolstad A, Olweus J (2015)
   "In situ" vaccination for systemic effects in follicular lymphoma
   Oncoimmunology, 4 (7), e1014773
   DOI 10.1080/2162402X.2015.1014773, PubMed 26140239
4. Liaskou E, Klemsdal Henriksen EK, Holm K, Kaveh F, Hamm D, Fear J, Viken MK, Hov JR, Melum E, Robins H, Olweus J, Karlsen TH, Hirschfield GM (2015)
   High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
   Hepatology, 63 (5), 1608-19
   DOI 10.1002/hep.28116, PubMed 26257205
5. Olweus J (2015)
   Cancer immunotherapy--Converting immune failure to clinical response
   Mol Oncol, 9 (10), 1891-3
   DOI 10.1016/j.molonc.2015.10.017, PubMed 26563645
6. Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S (2015)
   Unpredicted phenotypes of two mutants of the TcR DMF5
   J Immunol Methods, 425, 37-44
   DOI 10.1016/j.jim.2015.06.006, PubMed 26079729
7. Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J (2015)
   Soluble T-cell receptors produced in human cells for targeted delivery
   PLoS One, 10 (4), e0119559
   DOI 10.1371/journal.pone.0119559, PubMed 25875651

Publications 2014

1. Haugaa H, Taraldsrud E, Nyrerød HC, Tønnessen TI, Foss A, Solheim BG (2014)
   Low incidence of hyperfibrinolysis and thromboembolism in 195 primary liver transplantations transfused with solvent/detergent-treated plasma
   Clin Med Res, 12 (1-2), 27-32
   DOI 10.3121/cmr.2013.1168, PubMed 24415744
2. Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J (2014)
   High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
   Eur J Immunol, 44 (11), 3439-52
   DOI 10.1002/eji.201444662, PubMed 25103993
3. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
   Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
   Clin Exp Immunol, 175 (3), 439-48
   DOI 10.1111/cei.12239, PubMed 24237110

Publications 2013

1. Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF (2013)
   Non-allergic, mastocytosis-associated rhinitis
   Clin Exp Allergy, 43 (4), 406-12
   DOI 10.1111/cea.12053, PubMed 23517036
2. Kumari S, Wälchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J (2013)
   Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes
   Proc Natl Acad Sci U S A, 111 (1), 403-8
   DOI 10.1073/pnas.1306549111, PubMed 24344295
3. Wälchli S, Kumari S, Fallang LE, Sand KM, Yang W, Landsverk OJ, Bakke O, Olweus J, Gregers TF (2013)
   Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation
   Eur J Immunol, 44 (3), 774-84
   DOI 10.1002/eji.201343671, PubMed 24293164

Publications 2012

1. Banik D, Khan AN, Walseng E, Segal BH, Abrams SI (2012)
   Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity
   PLoS One, 7 (9), e45422
   DOI 10.1371/journal.pone.0045422, PubMed 23028998
2. Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH (2012)
   Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma
   PLoS One, 7 (10), e46117
   DOI 10.1371/journal.pone.0046117, PubMed 23049692
3. Olweus J, Kolstad A (2012)
   [Can the immune system target cancer?]
   Tidsskr Nor Laegeforen, 132 (7), 784-5
   DOI 10.4045/tidsskr.12.0156, PubMed 22511078
4. Zhen Y, Sørensen V, Skjerpen CS, Haugsten EM, Jin Y, Wälchli S, Olsnes S, Wiedlocha A (2012)
   Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1
   Traffic, 13 (5), 650-64
   DOI 10.1111/j.1600-0854.2012.01341.x, PubMed 22321063

Publications 2011

1. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J (2011)
   T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
   Int J Cancer, 130 (8), 1821-32
   DOI 10.1002/ijc.26209, PubMed 21630262
2. Koutra K, Chatzi L, Roumeliotaki T, Vassilaki M, Giannakopoulou E, Batsos C, Koutis A, Kogevinas M (2011)
   Socio-demographic determinants of infant neurodevelopment at 18 months of age: Mother-Child Cohort (Rhea Study) in Crete, Greece
   Infant Behav Dev, 35 (1), 48-59
   DOI 10.1016/j.infbeh.2011.09.005, PubMed 22018719
3. Sokołowska I, Wälchli S, Węgrzyn G, Sandvig K, Słomińska-Wojewódzka M (2011)
   A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation
   Biochem J, 436 (2), 371-85
   DOI 10.1042/BJ20101493, PubMed 21388347
4. Wälchli S, Løset GÅ, Kumari S, Johansen JN, Yang W, Sandlie I, Olweus J (2011)
   A practical approach to T-cell receptor cloning and expression
   PLoS One, 6 (11), e27930
   DOI 10.1371/journal.pone.0027930, PubMed 22132171

Publications 2010

1. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
   Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
   Leukemia, 24 (11), 1901-9
   DOI 10.1038/leu.2010.186, PubMed 20844564
2. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2010)
   Transiently redirected T cells for adoptive transfer
   Cytotherapy, 13 (5), 629-40
   DOI 10.3109/14653249.2010.542461, PubMed 21174490
3. Sanner H, Kirkhus E, Merckoll E, Tollisen A, Røisland M, Lie BA, Taraldsrud E, Gran JT, Flatø B (2010)
   Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study
   Arthritis Care Res (Hoboken), 62 (8), 1103-11
   DOI 10.1002/acr.20203, PubMed 20506141
4. Yamazaki T, Wälchli S, Fujita T, Ryser S, Hoshijima M, Schlegel W, Kuroda S, Maturana AD (2010)
   Splice variants of enigma homolog, differentially expressed during heart development, promote or prevent hypertrophy
   Cardiovasc Res, 86 (3), 374-82
   DOI 10.1093/cvr/cvq023, PubMed 20097676

Publications 2009

1. Gran JT, Molberg Ø, Dobloug GC, Andersson H, Taraldsrud E, Scheie D (2009)
   [Myositis-specific autoantibodies]
   Tidsskr Nor Laegeforen, 129 (16), 1631-4
   DOI 10.4045/tidsskr.09.35501, PubMed 19721478
2. Rölle A, Olweus J (2009)
   Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures
   APMIS, 117 (5-6), 413-26
   DOI 10.1111/j.1600-0463.2009.02449.x, PubMed 19400865
3. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
   Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
   Scand J Immunol, 69 (4), 319-28
   DOI 10.1111/j.1365-3083.2008.02223.x, PubMed 19284496

Publications 2007

1. Borresen P, Taraldsrud E, Berentsen SA (2007)
   [A three-year-old boy with bullous skin eruptions and paresis]
   Tidsskr Nor Laegeforen, 127 (15), 1950-2
   PubMed 17708060

Publications 2006

1. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006)
   Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
   N Engl J Med, 355 (12), 1199-209
   DOI 10.1056/NEJMoa055706, PubMed 16990383